Bosutinib reduces endothelial permeability and organ failure in a rat polytrauma transfusion model
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bosutinib reduces endothelial permeability and organ failure in a rat polytrauma transfusion model
Authors
Keywords
bosutinib, endothelial dysfunction, shock, transfusion, trauma, tyrosine kinase inhibitor
Journal
BRITISH JOURNAL OF ANAESTHESIA
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-03-07
DOI
10.1016/j.bja.2021.01.032
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bosutinib prevents vascular leakage by reducing focal adhesion turnover and reinforcing junctional integrity
- (2020) Liza Botros et al. JOURNAL OF CELL SCIENCE
- Towards patient-specific management of trauma hemorrhage: the effect of resuscitation therapy on parameters of thromboelastometry
- (2019) N.P. Juffermans et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Inhibition of spleen tyrosine kinase signaling protects against acute lung injury through blockade of NADPH oxidase and IL-17A in neutrophils and γδ T cells respectively in mice
- (2019) Ahmed Nadeem et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Reduction of vascular leakage by imatinib is associated with preserved microcirculatory perfusion and reduced renal injury markers in a rat model of cardiopulmonary bypass
- (2018) N.J. Koning et al. BRITISH JOURNAL OF ANAESTHESIA
- Safety and efficacy of second-line bosutinib for chronic phase chronic myeloid leukemia over a five-year period: final results of a phase 1/2 study
- (2018) Carlo Gambacorti-Passerini et al. HAEMATOLOGICA
- Bosutinib, dasatinib, imatinib, nilotinib, and ponatinib differentially affect the vascular molecular pathways and functionality of human endothelial cells
- (2018) Ayala Gover-Proaktor et al. LEUKEMIA & LYMPHOMA
- Endotheliopathy of Trauma is an on-Scene Phenomenon, and is Associated with Multiple Organ Dysfunction Syndrome
- (2018) David N. Naumann et al. SHOCK
- Safety and efficacy of second-line bosutinib for chronic phase chronic myeloid leukemia over a five-year period: final results of a phase 1/2 study
- (2018) Carlo Gambacorti-Passerini et al. HAEMATOLOGICA
- Elevated Syndecan-1 after Trauma and Risk of Sepsis: A Secondary Analysis of Patients from the Pragmatic, Randomized Optimal Platelet and Plasma Ratios (PROPPR) Trial
- (2018) Shuyan Wei et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Prehospital Plasma during Air Medical Transport in Trauma Patients at Risk for Hemorrhagic Shock
- (2018) Jason L. Sperry et al. NEW ENGLAND JOURNAL OF MEDICINE
- Washing or filtering of blood products does not improve outcome in a rat model of trauma and multiple transfusion
- (2018) Mathijs R. Wirtz et al. TRANSFUSION
- Syndecan-1: A Quantitative Marker for the Endotheliopathy of Trauma
- (2017) Erika Gonzalez Rodriguez et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Bosutinib more effective than imatinib in CML
- (2017) Elizabeth Gourd LANCET ONCOLOGY
- Endotheliopathy is associated with higher levels of cell-free DNA following major trauma: A prospective observational study
- (2017) David N. Naumann et al. PLoS One
- Contemporary Patterns of Multiple Organ Dysfunction in Trauma
- (2017) Joanna M. Shepherd et al. SHOCK
- Differential and opposing effects of imatinib on LPS- and ventilator-induced lung injury
- (2015) E. Letsiou et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Imatinib attenuates inflammation and vascular leak in a clinically relevant two-hit model of acute lung injury
- (2015) Alicia N. Rizzo et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Targeting Abl Kinases to Regulate Vascular Leak During Sepsis and Acute Respiratory Distress Syndrome
- (2015) A. N. Rizzo et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The clinically approved drugs dasatinib and bosutinib induce anti-inflammatory macrophages by inhibiting the salt-inducible kinases
- (2015) James Ozanne et al. BIOCHEMICAL JOURNAL
- Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe Trauma
- (2015) John B. Holcomb et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A simple method for the determination of Bosutinib in rat plasma by UPLC-MS/MS
- (2015) Yihua Xu et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Acute Coagulopathy of Trauma in the Rat
- (2013) Daniel N. Darlington et al. SHOCK
- Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure
- (2012) H. J. Khoury et al. BLOOD
- Effective Treatment of Edema and Endothelial Barrier Dysfunction With Imatinib
- (2012) Jurjan Aman et al. CIRCULATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search